Open‐Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women.
Saved in:
| Title: | Open‐Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women. |
|---|---|
| Authors: | Sykes, Andy1 (AUTHOR) andy.sykes@astrazeneca.com, Engman, Helena2 (AUTHOR), Taylor, Nigel3 (AUTHOR), Brier, Tim4 (AUTHOR), Maudsley, Rhiannon5 (AUTHOR), Kirova, Bistra6 (AUTHOR), Mathewson, Alastair M.4 (AUTHOR), Bragg, Ryan A.7 (AUTHOR), Gränfors, Malin8 (AUTHOR), Gangl, Eric T.9 (AUTHOR), Klinowska, Teresa10 (AUTHOR), Li, Yan9 (AUTHOR), Menakuru, Somasekhar R.11 (AUTHOR), Roe, Chris11 (AUTHOR), McDermott, John11 (AUTHOR), Lindemann, Justin P. O.4 (AUTHOR) |
| Source: | CTS: Clinical & Translational Science. Feb2026, Vol. 19 Issue 2, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
